Dietary fi ber intake provides many health benefi ts. A generous intake of dietary fi ber reduces risk for developing the diseases including coronary heart disease [Liu et al. 1999] , stroke [Steffen et al. 2003 ], hypertension [Whelton et al. 2005] , diabetes [Montonen et al. 2003 ], obesity [Lairon et al. 2005 ] and certain gastrointestinal disorders [Petruzziello et al. 2006] . Furthermore, increased consumption of dietary fi ber improves serum lipid concentrations [Brown et al. 1999] , lowers blood pressure [Keenan et al. 2002] [Watzl et al. 2005] .
INTRODUCTION www.food.actapol.net/ fermented to a limited extent in the colon [Anderson et al. 2009 ].
DEFINING DIETARY FIBER
In the simplest form, carbohydrates can be separated into two basic groups based upon their digestibility in the Gastro Intestinal (GI) tract. The fi rst group (i.e. starch, simple sugars, and fructans) is easily hydrolysed by enzymatic reactions and absorbed in the small intestine. These compounds can be referred to as non-structural carbohydrates, non-fi brous polysaccharides (NFC) or simple carbohydrates. The second group (i.e. cellulose, hemicellulose, lignin, pectin and beta-glucans) are resistant to digestion in the small intestine and require bacterial fermentation located in the large intestine. These compounds can be referred to as complex carbohydrates, non-starch polysaccharide (NSP) or structural carbohydrates and are refl ective in Neutral Detergent Fiber (NDF) and Acid Detergent Fiber (ADF) analysis. NSP can be further subdivided into the two general groups of soluble and insoluble. This grouping is based on chemical, physical, and functional properties. Soluble fi ber dissolves in water forming viscous gels. They bypass the digestion of the small intestine and are easily fermented by the microfl ora of the large intestine. They consist of pectins, gums, inulin-type fructans and some hemicelluloses. In the human GI tract, insoluble fi bers are not water soluble. They do not form gels due to their water insolubility and fermentation is severally limited. Some examples of insoluble fi ber are of lignin, cellulose and some hemicelluloses [James and Mark 2010] .
A recent description, as suggested by the American Association of Cereal Chemists, terms dietary fi ber as carbohydrate polymers with more than a three degree polymerization which are neither digested nor absorbed in the small intestine. The greater than three degree polymer rule was designed to exclude mono and disaccharides [AACC 2010] . The World Health Organization (WHO) and Food and Agriculture Organization (FAO) agree with the American Association of Cereal Chemists (AACC) defi nition but with a slight variation. They state that dietary fi ber is a polysaccharide with ten or more monomeric units which is not hydrolyzed by endogenous hormones in the small intestine [Codex... 2010] . The known constituents of dietary fi ber are listed in Table 1 .
Non Starch Polysaccharides (NSP) can be further subdivided into the two general groups of soluble and insoluble. This grouping is based on chemical, physical, and functional properties [Sizer and Whitney 2008] . Soluble fi ber dissolves in water forming viscous gels. They bypass the digestion in the small intestine and are easily fermented by the microfl ora of the large intestine. In the human GI tract, insoluble fi bers are not water soluble. They do not form gels due to their water insolubility and fermentation is severally limited. Most fi ber containing foods include approximately one-third soluble and two-third insoluble fi ber [Wong and Jenkins 2007] . Current recommendations for dietary fi ber intake are related to age, gender, and energy intake, and the general recommendation for adequate intake (AI) is 14 g/1000 kcal [USDA 2005] . This AI includes nonstarch polysaccharides, analogous carbohydrates (e.g., resistant starches), lignin, and associated substances [Witwer 2008] . Using the energy guideline of 2000 kcal/day for women and 2600 kcal/day for men, the recommended daily dietary fi ber intake is 28 g/day for adult women and 36 g/day for adult men.
HEALTH BENEFITS OF DIETARY FIBER

Cardiovascular
Cardiovascular diseases, including coronary heart disease (CHD), stroke, and hypertension, affect more than 80 million people and are the leading causes of morbidity and mortality in the United States. In 2005, CHD was the leading cause of death and strokes were the third leading cause of death in the United States [American... 2008] . While CHD is the most prevalent cause of death, it is probably the most modifi able; an estimated 82% of CHD is attributed to lifestyle practices such as diet, physical activity, and cigarette abuse [Stampfer et al. 2000] and 60% is attributed to dietary patterns [Kris-Etherton et al. 2002] .
High levels of dietary fi ber intake are associated with meaningfully lower prevalence rates for coroner heart disease, stroke, and peripheral vascular disease [Merchant et al. 2003 ]; major risk factors, such as hypertension, diabetes, obesity, and dyslipidemia, are also less common in individuals with the highest levels of fi ber consumption [Lairon et al. 2005] .
The impact of dietary fi ber or whole grain consumption on the prevalence of these conditions is summarized in Table 3 . In the analyses of prospective cohort studies, the observed protective effect of dietary fi ber intake was very similar to the effects of whole grains but "fellow travelers" with fi ber, such as magnesium, other minerals, vitamins, and antioxidants, may have signifi cant complementary benefi cial effects [Anderson 2004 .
Seven cohort studies presenting observations for over 158,000 individuals indicate that CHD disease prevalence is signifi cantly lower (29%) in individuals with the highest intake of dietary fi ber compared to those with the lowest intake (Table 3) . Specifi cally, the relative risk, computed by variance weighting (fi xedeffect metaanalysis) is 0.71 for individuals in the highest quintile for dietary fi ber intake compared to those in the lowest quintile [Anderson et al. 2009 ].
In the United States, CVD affects approximately one-third of the adult US population and CHD is the leading cause of death. Higher intakes of dietary fi ber compared to lower consumption levels are associated with signifi cantly lower rates of CVD and lower prevalence of CVD risk factors. Persons with the highest levels of fi ber consumption have a 29% lower risk for CHD than those with the lowest intakes. Soluble fi ber intake of about 6 g/day is accompanied by reductions in serum LDL-cholesterol values of around 5.4% and estimated risk for CHD of about 9%. Increased fi ber intake modestly lowers the blood pressure of the general population but is accompanied by reductions of systolic and diastolic blood pressure, respectively, of -6 mmHg and -4 mmHg for hypertensive individuals. Higher fi ber intakes are associated with improved measures for body weight, visceral adiposity, insulin sensitivity, and infl ammatory markers. Moderate increases in fi ber intake, especially soluble fi ber, are likely to have signifi cant favourable effects on risk and progression of CVD [Anderson et al. 2009 ]. Many studies support the inverse relationship of dietary fi ber and risk for CHD. However, more recent studies found interesting data illustrating that for every 10 g of additional fi ber added to a diet the mortality risk of CHD decreased by 17-35%. Risk factors for CHD include hypercholesterolemia, hypertension, obesity and type two diabetes. It is speculated that the control and treatment of these risk factors underlie the mechanisms behind DF and CHD prevention. First, soluble fi bers have been shown to increase the rate of bile excretion therefore reducing serum total and LDL cholesterol. Second, short chain fatty acid production, specifi cally propionate, has been shown to inhibit cholesterol synthesis. Third, dietary fi ber demonstrates the ability to regulate energy intake thus enhancing weight loss or maintenance of a healthier body weight. Fourth, either through glycemic control or reduced energy intake, dietary fi ber has been shown to lower the risk for type two diabetes. Fifth, DF has been shown to decrease pro-infl ammatory cytokines such as interleukin-18 which may have an effect on plaque stability. Sixth, increasing DF intake has been shown to decrease circulating levels of C-Reactive protein (CRP), a marker of infl ammation and a predictor for CHD [James and Mark 2010] .
In a long term clinical study, Jensen et al. [2004] reported that an increased daily consumption of bran signifi cantly decreased the risk of coronary heart disease in healthy adult men. This is most likely due to the data reported by Qureshi et al. [2002] who found that 10 g of rice bran consumed for eight weeks was able to decrease serum total cholesterol, LDL cholesterol and triglycerides. The mechanisms behind these effects may be twofold. The reduction in cholesterol levels is likely due to an increase in bile acid synthesis. Andersson et al. [2002] found that oat bran doubled the serum concentration of 7α-hydroxy-4-cholesten-3-one (α-HC), which is a metabolite in the synthesis of bile acids that is oxidized from 7α-hydroxycholesterol. The reduction in serum triglyceride levels may be a result of a decreased absorption of fat from the small intestine. Theuwissen and Mensink [2008] found that, many well-controlled intervention studies have shown that four major water-soluble fi ber types β-glucan, psyllium, pectin and guar gum effectively lower serum LDL cholesterol concentrations, without affecting HDL cholesterol or triacylglycerol concentrations. Furthermore, epidemiological studies suggest that a diet high in water-soluble fi ber protects against CVD. These fi ndings underlie current dietary recommendations to further increase water-soluble fi ber intake.
Obesity
Nearly 66% of U.S. adults are overweight or obese resulting in an increased risk of health problems including; diabetes, CVD, and certain types of cancer. Although there are multiple factors that could contribute to obesity, the primary cause is due to an increase in the energy absorption, energy expenditure ratio. Therefore, limiting energy absorption is critical when treating obesity. Scientists have taken this a step further and studied the effect of other dietary aspects that may serve in weight regulation, including dietary fi ber. Increasing dietary fi ber consumption may decrease energy absorption by way of diluting a diet's energy availability while maintaining other important nutrients [Lattimer and Haub 2010] . Substantial research has been conducted to evaluate the effect of dietary fi ber and body weight, most of all which show an inverse relationship between dietary fi ber intake and change in body weight. Tucker and Thomas [2009] supported this statement in a study consisting of 252 middle aged women. They observed that over a 20 month period participants lost an average of 4.4 lbs due to an 8 g increase in dietary fi ber per 1000 kcal. This weight loss was primarily due to decreased body fat. It should be recognized that the correlation between dietary fi ber and weight change was independent of many other potential factors including age, baseline fi ber and fat intakes, activity level, and baseline energy intake.
Koh-Banerjee et al. [2004] concur with the above fi ndings and also suggest a dose-response relationship. They reported that for every 40 g/d increase in whole grain intake, weight gain decreased by 1.1 lbs. Moreover, bran seemed to play an important role in the reduction of weight gain by 0.8 lbs per 20 g/d intake.
Dietary fi ber's ability to decrease body weight or attenuate weight gain could be contributed to several factors. First, soluble fi ber, when fermented in the large intestine, produces glucagon-like peptide (GLP-1) and peptide YY (PYY). These two gut hormones play a role inducing satiety. Second, dietary fi ber may signifi cantly decrease energy intake [Tucker and Thomas 2009] . Women who consumed increased levels of fi ber tended to also have a decreased consumption of dietary fat. Third, dietary fi ber may decrease a diet metabolizable energy (ME), which is gross energy minus the energy lost in the feces, urine and combustible gases. Baer et al. [1997] observed that an increased consumption of dietary fi ber resulted in a decrease in the ME of the diet. This may be attributed to the fact that fat digestibility decreased as dietary fi ber increased. Also, as dietary fi ber intake increases, the intake of simple carbohydrates tends to decrease. Although, dietary fi ber still contributes to the total caloric content of a diet, it is much more resistant to digestion by the small intestine and even somewhat resistant in the large intestine.
Both soluble and insoluble fi ber may lead to weight loss. However, there seems to be a relationship between the type of diet (high or low fat) and the type of fi ber consumed. Insoluble fi ber may play a more important role for weight loss during consumption of a high fat diet. Since resistant starch is a constituent of dietary fi ber and undergoes the same digestion as insoluble fi ber, comparing resistant starch and insoluble fi ber may give us a better understanding of how dietary fi ber can be used to treat and prevent obesity. Adding resistant starch to a diet dilutes its ME, but not to the degree of insoluble fi ber. Numerous studies have found the same inverse relationship between dietary fi ber and weight gain , Du et al. 2010 .
Diabetes
Type two diabetes has increased exponentially over the past several years. Since 1990, self reported diabetes increased by 61% [Mokdad et al. 2003 ]. Although other risk factors such as obesity, lack of physical activity and smoking are precursors for the disease, dietary factors also seem to play a signifi cant role. Type two diabetes results from decreased insulin sensitivity and hyperglycemia. For that reason, a primary dietary factor of particular concern is carbohydrate intake [Lattimer and Haub 2010] . Meyer et al. [2000] observed that total carbohydrates had no effect on the risk of diabetes. However, the type of carbohydrate (non structural carbohydrates and dietary fi ber) was signifi cantly related. Therefore, it is important to understand a foods glycemic index or load. Glycemic index ranks total carbohydrate intake according to their immediate postprandial glucose response in comparison to a reference group such as glucose or white bread. Carbohydrates with a low glycemic index result in a smaller glucose/insulin response. Simple small chain carbohydrates would be considered to have a higher glycemic index since it produces higher blood glucose concentrations. Hu et al. [2001] found that excess body fat was the single most important determinant of type two diabetes, poor nutrition was also a large infl uential factor. Moreover, women consuming a poor diet signifi cantly increased their risk of developing type two diabetes. Poor diet was classifi ed as a diet high in saturated fat, low dietary fi ber and high non structural carbohydrates. This diet would be consistent with a high glycemic load being higher in easily digestible and rapidly absorbable carbohydrates [Hu et al. 2001] . In a supportive, long term (eight year) study of over 90,000 female nurses, Schulze et al. [2004] found a positive correlation between glycemic index and risk of type two diabetes. This association was signifi cant even after adjusting for age, body mass index (BMI) and family history. Several means have been proposed to understand the physiology behind the relationship of glycemic index and diabetes. First, carbohydrates with a higher glycemic index produce higher blood glucose levels. This chronic hyperglycemia is suggested to lead to the dysfunction of beta cells in the pancreas thus decreasing insulin release. Second, due to an over abundance of energy (i.e., high glycemic load) tissues such as skeletal muscle, liver and adipose become resistant to insulin. It is important to note that the inverse relationship between dietary fi ber and diabetes observed by Meyer et al. [2000] and Schulze et al. [2004] was independent of age and body weight. Hu et al. [2001] supported these fi ndings while correcting for age, fat intake, smoking, alcohol, family history, exercise, and body weight. Therefore, it seems that dietary fi ber is associated with type two diabetes, independent of other compounding factors.
Meyer et al.
[2000] using healthy middle aged women, observed a strong (P = 0.0012) inverse relationship between insoluble fi ber and the risk of type two diabetes while soluble fi ber had no effect. Montonen et al. [2003] also found the same results in healthy middle aged men and women consuming increased levels of whole rye bread. Interestingly, fi ber from fruits and vegetables had no effect on the risk of developing type two diabetes. Earlier studies have agreed with these fi ndings. A large epidemiological study of 42,000 men found that dietary fi ber from fruits or vegetables had no effect on the risk of diabetes. However, dietary fi ber from whole cereal grains showed a signifi cant decrease in diabetes occurrence. Daily intakes of fi ber among all groups were similar [Salmeron et al. 1997] . Weickert and Pfeifer [2008] found that an increased intake of cereal fi ber signifi cantly improved whole body glucose disposal resulting in an 8% improvement of insulin sensitivity. This suggests that the mechanisms behind insoluble fi ber are more peripheral and not limited to nutrient absorption. First, an accelerated secretion of glucose-dependent insulintropic polypeptide (GIP) was observed directly after the ingestion of an insoluble fi ber in healthy women. GIP is an incretin hormone which stimulates postprandial insulin release. Second, insoluble fi ber can result in a reduced appetite and food intake [Samra and Anderson 2007] and this may lead to a decreased caloric intake and BMI. Third, short chain fatty acids, via fermentation, have been shown to reduce postprandrial glucose response [Ostman et al. 2002] . Early research demonstrated that lipid infusions impaired glucose utilization and oral acetate could decrease free fatty acids (FFA) in the blood. According to Kelley and Mandarino [2000] increases in FFA in the blood can inhibit glucose metabolism through the inhibition of GLUT 4 transporters. Therefore, short chain fatty acids, by way of decreasing serum free fatty acids, may reduce blood glucose levels through competition in insulinsensitive tissues.
The inverse relationship between cereal grains and diabetes may also be attributed to an increased consumption of magnesium. Increased intake of magnesium has been shown to decrease the incidence of type two diabetes [Meyer et al. 2000] . Hypomagnesemia is common among diabetics and has been associated with a reduction of tyrosine kinase at the insulin receptor. This may impair the action of insulin thus leading to insulin resistance [Paolisso and Barbagallo 1997] .
Gastrointestinal
Dietary fi bers affect the entire gastrointestinal tract from the mouth to the anus. High-fi ber foods usually have lower energy density and take longer to eat [Haber et al. 1977] . Soluble fi bers usually delay gastric emptying. Soluble fi bers may act to slow transit of food materials through the small intestine while insoluble fi bers tend to create "intestinal hurry" [Cummings 2001] . In the small intestine, dietary fi bers can reveal responses of a wide variety of gastrointestinal hormones that serve as incretins to stimulate insulin release and affect appetite [Anderson 2008 ]. Some fi bers bind bile acids and impede micelle formation, thus increasing fecal excretion of bile acids and cholesterol [Kirby et al. 1981 ]. In the colon, fermentable fi bers increase bacterial mass with some acting as prebiotics to promote health-promoting bacteria such as Lactobacilli and Bifi dobacteria [Roberfroid 2005 ]. Insoluble fi bers are especially effective in increasing fecal mass and promoting regularity [Cummings 2001 ].
Recently Drzikova et al. [2005] found that the in vitro binding of bile acids increased with increasing proportions of oat bran, total and insoluble dietary fibre, as well as b-glucan, in pre-digested oat-based extrudates. The results of the study show, that the source, the chemical composition and the pre-treatment of dietary fibre preparations strongly influence their ability to interact with bile acids.
The consumption of b-glucan and resistant starchrich diets results in several beneficial physiological effects. Thus, b-glucan lowers the postprandial blood glucose and insulin responses in normal individual. Serum cholesterol and lipoprotein concentrations can be reduced in humans and animals by b-glucans from oat and barley or by cereal products. A reason for the cholesterol-lowering effects of b-glucan-rich diets may be the greater excretion of bile acids [Drzikova et al. 2005] .
Early observers suggested that dietary fi ber intake decreased the prevalence of hiatal hernias and gastroesophageal refl ux disease (GERD), peptic ulcer disease, gallbladder disease, appendicitis, diverticular disease, colorectal cancer, and hemorrhoids [Burkitt and Trowell 1975] . Rigorous evaluation of the prevalence of these diseases suggests that high levels of dietary fi ber intake, compared to low levels, may be associated with a decreased prevalence of the following conditions: esophageal cancer [Wu et al. 2007 ], GERD [El-Serag et al. 2005] , gastric cancer [Wu et al. 2007] , peptic ulcer disease [Aldoori et al. 1997] , gallbladder disease [Tsai et al. 2004] , diverticular disease [Aldoori et al. 1997] , constipation and hemorrhoids [Cummings 2001] .
Limited data suggest that individuals with higher fi ber intakes have a lower prevalence of GERD [El-Serag et al. 2005] . Guar gum and, possibly, other soluble fi bers are associated with low levels of gastric acid production, which may protect from GERD and duodenal ulcer disease. The available evidence strongly indicates that high fi ber intakes are associated with lower prevalence of duodenal ulcer disease. The available evidence strongly indicates that high fi ber intakes are associated with lower prevalence of duodenal ulcer disease than lower fi ber intakes, and the epidemiological evidence is moderately well supported by clinical trials [Ryan-Harshman and Aldoori 2004] .
Irritable bowel syndrome is one of the most common gastrointestinal functional disorders worldwide. It is a complex disorder and includes the following symptoms: abdominal pain or discomfort, bloating, and diarrhea and/or constipation. While wheat bran often increases symptoms other fi ber supplements such as methylcellulose, partially hydrolysed guar gum, and psyllium have been reported to alleviate symptoms [Anderson et al. 2009 ]. In clinical trials, reductions in symptoms in groups receiving placebo, as well as those receiving fi ber are usually dramatic and statistically signifi cant, thus confounding the assessment of the therapeutic intervention. The sympathetic support of the primary care provider combined with highly selective therapeutic interventions with dietary fi ber in foods or supplements can often be very effective in reducing symptoms [Giannini et al. 2006] . Judicious use of soluble fi bers may offer benefi ts for persons with ulcerative colitis in remission [Seidner et al. 2005] . Diverticular disease is the fi fth most common gastrointestinal condition in Western countries and is one of the classical fi ber-defi ciency diseases. A generous intake of dietary fi ber is considered to be protective, ameliorative, and preventive of recurrences [Frieri et al. 2006] . Increased intake of dietary fi ber is commonly used for the prevention and management of constipation or hemorrhoids. Wheat bran, high-fi ber cereals, and fi ber supplements are widely used by consumers, which represents common knowledge of their beneficial effects [Anderson et al. 2009] .
Inulin has demonstrated the ability to contribute to the health of the human large intestine as a prebiotic. They demonstrated that inulin stimulated the growth of Bifi dobacteria while restricting the growth of potential pathogenic bacteria such as E. coli, Salmonella, and Listeria. This could prove to be benefi cial in such disorders as ulcerative colitis and C. diffi cile infections. Rafter et al. [2007] agreed with these fi ndings and suggested they were the underlying mechanisms behind the observation that inulin decreased biological compounds associated with colonic cancer, including reduced colorectal cell proliferation and water induced necrosis, decreased exposure to genotoxins, and decreased interleukin-2 release. www.food.actapol.net/ Several recent clinical studies showed that oral pectin supplementation to children and infants reduced acute intestinal infections and signifi cantly slowed diarrhea. This is thought to be due to a reduction in pathogenic bacteria such as Shigella, Salmonella, Klebsiella, Enterobacter, Proteus and Citrobacter. This is supported by Olano-Martin et al. [2002] who observed that pectin stimulated the growth of certain strains of Bifi dobacteria and Lactobacillus in vitro. These bacteria are considered to be directly related to the health of the large intestine and their concentrations depict a healthy microfl ora population. Kahlon et al. [2001] found that high-fi ber diets fed to rats resulted in signifi cantly greater wet and dry fecal weights than low-fi ber diets. Bran diets resulted in signifi cantly higher fecal moisture than cellulose diets. Cecum lengths increased signifi cantly with bran diets compared with cellulose diets. The wheat bran diet resulted in signifi cantly higher stomach weights than with cellulose diets. Stomachs were heavier and cecal lengths were greater with bran diets than with cellulose diets; however, a high-cellulose diet resulted in increased colon weight. Except for higher fi ber digestibility of coarse bran, bran particle size had no signifi cant effects. Healthful effects of wheat bran may be associated with gastrointestinal morphology and function. Fecal bulking and decreased intestinal transit time can prevent constipation and may dilute or reduce absorption of toxic or carcinogenic metabolites, thus improving gastrointestinal health and lowering the risk of tumor development and cancer. Ferguson and Harris [1996] found that two groups of mechanisms have been proposed for the way dietary fi bres may protect against colorectal cancer: those in which the dietary fi bre may act directly and those in which the dietary fi bre may have an indirect effect as a consequence of it being degraded by colonic bacterial enzymes and the products fermented.
Cancer
Cancer continues to be one of the number one health concerns of populations worldwide. Most cancers strike both men and women at about the same rate, with exception of cancers of the reproductive system. Of particular concern is cancer of the colon, ranking among the top 3 forms of cancer in the U.S.A., for both men and women. Colon cancer is also one of the leading causes of cancer morbidity and mortality among both men and women in the Western countries, including the U.S.A. Historical observational and epidemiological studies from around the world have long supported that increased consumption of fruits and vegetables and high fi ber intake provide a protective relationship between dietary fi ber intake and colon cancer incidence. Early results from a European investigation, the European Prospective Investigation of Cancer (EPIC), involving more than half a million people in 10 European countries, indicates that dietary fi ber provides strong protective effects against colon and rectal cancers. Poorly fermented fi ber, such as that in cereal brans, has direct effects in the colon by promoting laxation, decreasing transit time, and binding substances such as bile acids and carcinogens. However, evidence to date is insuffi cient to determine if decreased colon cancer risk is a benefi cial effect of this type of fi ber. Of particular interest is the utilization of fermentable fi ber by the colonic microbiota that can result in changes to the numbers and types of bacteria and, more importantly, changes to their metabolic activities in terms of the formation of genotoxins, carcinogens, and tumor promoters. Selective prebiotic fi ber sources, such as inulin, resistant starches, and some oligosaccharides, act as selective substrate for bacteria that produce specifi c short-chain fatty acids (SCFA) and can lower the intestinal pH. The SCFA butyrate has been shown to increase apoptosis in human colonic tumor cell lines. Apoptosis is a mechanism where excess or redundant cells are removed during development and restricted tissue size is maintained. The apoptosis process is thus an innate cellular defense against carcinogenesis. Evidence suggests that increasing the numbers of Bifi dobacteria in the colon and reducing intestinal pH has a direct impact on carcinogenesis in the large intestine. Possible mechanisms for the anticarcinogenic and antitumorigenic effect of highly fermentable fi bers are not completely understood and require further research. However, it is likely that some or all are involved in a metabolic chain reaction for the inhibitory effect to ocur. The primary mechanisms involved with these effects are proposed to be: a reduction in the production of carcinogenic substances by decreasing the amount of pathogenic bacteria in the colon [Rumney and Rowland 1995] ; and/or lowering the colonic pH to affect pH-dependent enzymatic reactions; for example, secondary bile acid formation [Rowland et al. 1998 ]; and/or reducing the amount of carcinogenic substances available to colonic mucosa by adsorption of the substances to the cell wall of the microbiota, by speeding up the intestinal transit time and by increasing colonic contents and thus diluting all components; and/or exerting inhibiting effects on initiation and promotionstages in colon cancer formation in which SCFA, particularly butyric acid, may play a key role [Tungland and Meyer 2006] .
Immune system
Inulin and other oligofructoses have been the most extensively studied dietary fi bers. They act, to stimulate growth of bifi dobacteria in the colon. Bifi dobacteria and lactobacilli are healthpromoting bacteria that generate short-chain fatty acids and stimulate the immune system. Fairly extensive animal studies have documented the favourable effect of inulin on the immune system and preliminary studies in humans support the hypotheses generated from animal studies. Inulin and oligofructoses are not digested by pancreatic enzymes thus, they enter the colon virtually intact. In the colon, inulin is fermented completely by the microbacteria and it promotes the growth of bifi dobacteria. Short-chain fatty acids (SCFA) result from this fermentation process. Other fi bers are also fermented to generate SCFA, but the bifi dobacteria effects of non-oligofructose fi bers are not as well characterised. The proposed health benefi ts of bifi dobacteria include the following:
• protection from intestinal infection • lowering of intestinal pH for formation of acids after assimilation of carbohydrates • reduction of the number of potentially harmful bacteria; production of vitamins and antioxidants • activation of intestinal function and assistance in digestion and absorption, especially of calcium • bulking activity to prevent and treat constipation • stimulation of the immune response • potential reduction in the risk for colorectal cancer.
Limited studies in humans have indicated that inulin supplementation increases the fecal bacterial contents of bifi dobacteria and has favourable effects on the types and amounts of circulating lymphocytes. Inulin and oligofructoses have been studied most extensively, but favourable effects of fermentable soluble fi bers have been demonstrated for oat b-glucan, gumArabic, and others.
The role of prebiotic fi bers in infant nutrition and health, especially for non-breastfed infants, is generating a great deal of interest. The studies suggest that supplementation with a prebiotic fi ber mixture has the following benefi ts: promotes postnatal immune development, decreases respiratory infections and atopic dermatitis and improves bowel function.
The therapeutic potential for using prebiotic fi bers in the treatment of infl ammatory bowel disease is being examined. In animal studies, prebiotic fi bers have reduced gut infl ammation in a number of animal experimental models. Early studies also indicate that prebiotic fi bers signifi cantly reduce the risk of infection in liver transplant patients. Preliminary human studies have shown favourable responses for individuals with ulcerative colitis, Crohn's disease, or pouchitis [Anderson et al. 2009 ].
Mineral bioavailability
Certain fi ber sources from fruits and vegetables that have cation exchange capacity from unmethylated galacturonic acid residues and phytic acid from cereal fi bers, have been found to depress the absorption and retention of several minerals. However, certain highly fermentable fi bers have resulted in improved metabolic absorption of certain minerals, such as calcium, magnesium, and iron, even when phytic acid is present at lower concentrations. These compounds include pectin, various gums, resistant starches, cellulose, certain oligosaccharides like soy and fructooligosaccharides, inulin, lactulose, and related sugars. Mineral absorption has generally been accepted as stemming from diffusion in the small intestine. However, studies now indicate that highly fermentable fi bers, such as inulin and fructooligosaccharides, also promote mineral absorption in the colon. Through their fermentation by colonic microbiota and subsequent SCFA production, these fi ber components stimulate the proliferation of epithelial cells in the cecocolon and reduce the luminal pH. Al salts, especially calcium, magnesium, and iron, in the luminal content and increase their diffusive absorption via the paracellular route. In particular, the accumulation of calcium phosphate in the large intestine and the solubilization of minerals by SCFA are likely to play an essential role in the enhanced mineral www.food.actapol.net/ absorption in the colon. Also, a recent study has demonstrated that fructooligosaccharides (inulin) stimulate the transcellular route of calcium absorption in the large intestine, as indicated by increased concentrations of calbindin-D9k, a calcium binding protein that plays an important role in intestinal calcium transport [Tungland and Meyer 2006] .
CONCLUSIONS
In a simplifi ed defi nition, dietary fi ber is a carbohydrate that resists digestion and absorption and may or may not undergo microbial fermentation in the large intestine. This defi nition is essentially the basis to its correlation between consumption levels and possible health benefi ts. Dietary fi ber consists of many different constituents, however; some are of particular interest and include arabinoxylan, inulin, β-glucan, pectin, bran and resistant starches. These individual components of dietary fi ber have been shown to signifi cantly play an important role in improving human health. Current research is paying particular attention to these elements although further research is needed to better understand particular health claims and the mechanisms involved. A high level of fi ber intake has health-protective effects and disease-reversal benefi ts. Persons who consume generous amounts of dietary fi ber, compared to those who have minimal fi ber intake, are at lower risk for developing; Cardiovascular health disease, hypertension, diabetes, obesity, and certain gastrointestinal diseases. Increasing the intake of high fi ber foods or fi ber supplements improves serum lipoprotein values, lowers blood pressure, improves blood glucose control for diabetic individuals, aids weight loss, and improves regularity.
